Johnson & Johnson Reports 2018 Third-Quarter Results:
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Johnson & Johnson (JNJ) PT Raised to $150 at RBC Capital
October 17, 2018 7:49 AM EDTRBC Capital analyst Glenn Novarro raised the price target on Johnson & Johnson (NYSE: JNJ) to $150.00 (from $143.00) while maintaining an Outperform rating following Q3 results.
Novarro notes Pharma excelled again, and the Devices & Consumer segments are heading in the right direction.
The... More
Johnson & Johnson (JNJ) Tops Q3 EPS by 2c, Updates FY Guidance
October 16, 2018 6:41 AM EDTJohnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.05, $0.02 better than the analyst estimate of $2.03. Revenue for the quarter came in at $20.3 billion versus the consensus estimate of $20.03 billion.
GUIDANCE:
Johnson & Johnson sees FY2018 EPS of $8.13-$8.18, versus the consensus of... More
